Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis.

Brown JR, Moslehi J, Ewer MS, O'Brien SM, Ghia P, Cymbalista F, Shanafelt TD, Fraser G, Rule S, Coutre SE, Dilhuydy MS, Cramer P, Jaeger U, Dreyling M, Byrd JC, Treon S, Liu EY, Chang S, Bista A, Vempati R, Boornazian L, Valentino R, Reddy V, Mahler M, Yang H, Graef T, Burger JA
Br J Haematol. 2019 184 (4): 558-569

PMID: 30506764 · PMCID: PMC6587776 · DOI:10.1111/bjh.15690

MeSH Terms (13)

Aged Female Hematologic Neoplasms Hemorrhage Humans Incidence Male Middle Aged Pyrazoles Pyrimidines Randomized Controlled Trials as Topic Risk Factors Time Factors

Connections (1)

This publication is referenced by other Labnodes entities:

Links